These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 974882)

  • 1. Toxicity testing in vitro. II. Use of a microsome - cultured human fibroblast system to study the cytotoxicity of cyclophosphamide.
    Cooper JT; Goldstein S
    Can J Physiol Pharmacol; 1976 Aug; 54(4):546-50. PubMed ID: 974882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclophosphamide and ifosfamide on neuroblastoma cells before and after activation by microsomes.
    Meyer T; Wierse G; Weinrebe W; Treuner J; Niethammer D; Bruchelt G
    Anticancer Res; 1997; 17(2A):981-6. PubMed ID: 9137438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cyclophosphamide and adriamycin on rat hepatic microsomal glucuronidation and lipid peroxidation.
    Lear L; Nation RL; Stupans I
    Biochem Pharmacol; 1992 Aug; 44(4):747-53. PubMed ID: 1510722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of co-medicated drugs on cyclophosphamide bioactivation in human liver microsomes.
    de Jonge ME; Huitema AD; van Dam SM; Rodenhuis S; Beijnen JH
    Anticancer Drugs; 2005 Mar; 16(3):331-6. PubMed ID: 15711186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro metabolic activation assay using liver microsomes in diffusion chambers: induction of sister chromatid exchanges and chromosome aberrations by cyclophosphamide or ifosfamide in cultured human and Chinese hamster cells.
    Huang CC; McKernan K; Pantano JR; Sirianni SR
    Carcinogenesis; 1980 Jan; 1(1):37-40. PubMed ID: 22282978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
    Murray M; Butler AM; Stupans I
    J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.
    Choi JM; Oh SJ; Lee JY; Jeon JS; Ryu CS; Kim YM; Lee K; Kim SK
    Chem Res Toxicol; 2015 May; 28(5):872-85. PubMed ID: 25860621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel enzyme-prodrug combinations for use in cytochrome P450-based gene therapy for cancer.
    Baldwin A; Huang Z; Jounaidi Y; Waxman DJ
    Arch Biochem Biophys; 2003 Jan; 409(1):197-206. PubMed ID: 12464259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide teratogenesis: a review.
    Mirkes PE
    Teratog Carcinog Mutagen; 1985; 5(2):75-88. PubMed ID: 2859667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male rats.
    McClure MT; Stupans I
    Biochem Pharmacol; 1992 Jun; 43(12):2655-8. PubMed ID: 1632821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cyclophosphamide for in vitro testing of cell sensitivity.
    Shrivastav S; Stone KR; Paulson DF; Bonar RA
    Cancer Res; 1980 Dec; 40(12):4443-5. PubMed ID: 7438076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide-impaired regulation of hepatic heme metabolism.
    Rizzardini M; Ferraroli A; Dal Fiume D; Cantoni L
    Experientia; 1984 Dec; 40(12):1390-2. PubMed ID: 6548974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of finoptin on the metabolism and pharmacological action of cyclophosphane in vivo and in vitro].
    Donenko FV; Chikvashvili BSh; Borovkova NB; Devichenskiĭ VM; Kabieva AO; Korneva EN; Telegin LIu; Shcherbakov VM; Letiagin VP; Moroz LV
    Biull Eksp Biol Med; 1991 Mar; 111(3):300-2. PubMed ID: 2054511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mixed hepatocyte-fibroblast culture system and its use as a test for metabolism-mediated cytotoxicity.
    Fry JR; Bridges JW
    Biochem Pharmacol; 1977 May; 26(10):969-73. PubMed ID: 861044
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomers.
    Foster AB; Jarman M; Kinas RW; van Maanen JM; Taylor GN; Gaston JL; Parkin A; Richardson AC
    J Med Chem; 1981 Dec; 24(12):1399-403. PubMed ID: 7310816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro kinetics of coumarin 3,4-epoxidation: application to species differences in toxicity and carcinogenicity.
    Born SL; Caudill D; Smith BJ; Lehman-McKeeman LD
    Toxicol Sci; 2000 Nov; 58(1):23-31. PubMed ID: 11053537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ketoconazole on cyclophosphamide metabolism: evaluation of CYP3A4 inhibition effect using the in vitro and in vivo models.
    Yang L; Yan C; Zhang F; Jiang B; Gao S; Liang Y; Huang L; Chen W
    Exp Anim; 2018 Feb; 67(1):71-82. PubMed ID: 29129847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervention of transplantable human mammary carcinoma MX-1 chemotherapy with dietary menhaden oil in athymic mice: increased therapeutic effects and decreased toxicity of cyclophosphamide.
    Shao Y; Pardini L; Pardini RS
    Nutr Cancer; 1997; 28(1):63-73. PubMed ID: 9200152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.